Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: Voller Fokus auf NurExone Biologic!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
38 Leser
Artikel bewerten:
(0)

Global ADME-Toxicology Testing Market 2015-2019 - Advances in Technology with Accelrys, Agilent Technologies, Bio-Rad Laboratories, Promega, Sigma Aldrich & Thermo Fisher Scientific Dominating

DUBLIN, July 01, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vjj8n3/global) has announced the addition of the "Global ADME-Toxicology Testing Market 2015-2019" report to their offering.

The global ADME-toxicology testing market to grow at a CAGR of 10.65% over the period 2014-2019.

ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment.

The emergence of cell-based assays in the drug development process has enabled drug manufacturers to use the right technology in conducting ADME-toxicology testing and reduce the duration of the drug approval process.

According to the report, the increase in demand for various toxicology testing procedures from biotechnology and pharmaceutical companies is one of the major drivers of the market. These tests help evaluate the safety profile of a drug, thus reducing the duration of the drug approval process.

Further, the report states that the high cost of the test is a major challenge hindering market growth.

To calculate the market size, revenue generated from the sales of products (instruments, assays systems, software solutions, and reagents) used in the following ADME-toxicology testing technologies:

  • In vivo: test performed inside a living organism for drug evaluation
  • In vitro: test performed in a laboratory (outside of a living cell)

Key Vendors

  • Accelrys (Dassault Systemes)
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Promega
  • Sigma Aldrich
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Cyprtorex
  • CytoPulse
  • Entelos
  • LI-COR Biosciences
  • Mattek
  • Miltenyi Biotec
  • Molecular Toxicology
  • Quintiles
  • RTI Health Solutions
  • SBW
  • Xenobiotic Detection Systems
  • Xenometrix

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. ADME-Toxicology Testing
  8. Market Segmentation by Technology
  9. Global In vivo Technology Market
  10. Global In vitro Technology Market
  11. Geographical Segmentation
  12. Buying Criteria
  13. Market Growth Drivers
  14. Drivers and their Impact
  15. Market Challenges
  16. Impact of Drivers and Challenges
  17. Market Trends
  18. Trends and their Impact
  19. Vendor Landscape
  20. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/vjj8n3/global

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.